Informed consent decision-making in deep brain stimulation [PDF]
Deep brain stimulation (DBS) has proved useful for several movement disorders (Parkinson’s disease, essential tremor, dystonia), in which first and/or second line pharmacological treatments were inefficacious.
Appelbaum +6 more
core +2 more sources
Value of MRI Outcomes for Preventive and Early‐Stage Trials in Spinocerebellar Ataxias 1 and 3
ABSTRACT Objective To examine the value of MRI outcomes as endpoints for preventive and early‐stage trials of two polyglutamine spinocerebellar ataxias (SCAs). Methods A cohort of 100 participants (23 SCA1, 63 SCA3, median Scale for the Assessment and Rating of Ataxia (SARA) score = 5, 42% preataxic, and 14 gene‐negative controls) was scanned at 3T up ...
Thiago J. R. Rezende +26 more
wiley +1 more source
Poststroke Neuropsychiatric Symptoms and Pseudoseizures [PDF]
LESSONS LEARNED AT THE INTERFACE OF MEDICINE AND PSYCHIATRY: The Psychiatric Consultation Service at Massachusetts General Hospital (MGH) sees medical and surgical inpatients with comorbid psychiatric symptoms and conditions. Such consultations require the integration of medical and psychiatric knowledge. During their thrice-weekly rounds, Dr.
Jeff C., Huffman, Theodore A., Stern
openaire +2 more sources
Behavioural and psychological symptoms in dementia and the challenges for family carers: systematic review [PDF]
Background: Tailored psychosocial interventions can help families to manage behavioural and psychological symptoms in dementia (BPSD), but carer responses to their relative's behaviours contribute to the success of support programmes. Aims: To understand
Alexandra Feast +15 more
core +3 more sources
FDG‐PET Associations With Disease Severity and Outcomes in NMDA‐Receptor IgG Autoimmune Encephalitis
ABSTRACT Background Patients with N‐methyl‐D‐aspartate (NMDA) receptor‐immunoglobulin G (IgG) autoimmune encephalitis (NMDAR‐IgG AE) demonstrate occipital lobe hypometabolism on baseline brain fluorodeoxyglucose‐positron emission tomography (bFDG‐PET).
Jonathan K. Lee +7 more
wiley +1 more source
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane +43 more
wiley +1 more source
Neuropsychiatric symptoms and their impact on quality of life in multiple system atrophy
Background: Multiple system atrophy (MSA) is a sporadic neurodegenerative disorder characterized by severe dysautonomia and atypical Parkinsonism or cerebellar dysfunction.
R. Ceponiene +4 more
doaj +1 more source
Impact of Neuropsychiatric Symptoms on the Quality of Life of Subjects with Parkinson’s Disease
Background: Neuropsychiatric symptoms in Parkinson’s disease (PD) are frequent. Impact of neuropsychiatric symptoms on quality of life has recently become a relevant topic of research due to its potential to develop targeted therapies to improve quality ...
Alonso Alvarado-Bolaños +8 more
doaj +1 more source
Neuropsychiatric symptoms in dementia
Neuropsychiatric symptoms (NPS), such as sadness and agitation, are common in people with mild cognitive impairment or dementia. NPS are distressing for both the person with a cognitive impairment and those around them. In this thesis, the relationship between the psychosocial environment and NPS in cognitive impairment was investigated.
openaire +2 more sources
‘Hearts and minds’: association, causation and implication of cognitive impairment in heart failure [PDF]
The clinical syndrome of heart failure is one of the leading causes of hospitalisation and mortality in older adults. An association between cognitive impairment and heart failure is well described but our understanding of the relationship between the ...
Cannon, Jane A. +2 more
core +4 more sources

